Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM; SENSCIS Trial Investigators. Distler O, et al. Among authors: kuwana m. N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112379 Free article. Clinical Trial.
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine.
Lescoat A, Bellando-Randone S, Campochiaro C, Del Galdo F, Denton CP, Farrington S, Galetti I, Khanna D, Kuwana M, Truchetet ME, Allanore Y, Matucci-Cerinic M. Lescoat A, et al. Among authors: kuwana m. Lancet Rheumatol. 2023 Nov;5(11):e683-e694. doi: 10.1016/S2665-9913(23)00212-6. Epub 2023 Sep 26. Lancet Rheumatol. 2023. PMID: 38251534 Review.
The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial.
Inoue Y, Kitamura H, Okamoto M, Ogura T, Nishioka Y, Kuwana M, Taniguchi A, Ito T, Rohr KB, Suda T. Inoue Y, et al. Among authors: kuwana m. Respir Investig. 2024 Apr 30;62(4):589-596. doi: 10.1016/j.resinv.2024.04.008. Online ahead of print. Respir Investig. 2024. PMID: 38692040 Free article.
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges.
Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, Kadam E, Shinjo SK, Dey D, Cavagna L, Makol A, Gutiérrez CET, Caballero Uribe CV, Kuwana M, Burmester GR, Ziade N, Wincup C, Andreoli L, Parodis I, Tan AL, Guillemin F, Knitza J, Wang G, Dalbeth N, Velikova T, Gracia-Ramos AE, Nikiphorou E, Day J, Chinoy H, Aggarwal R, Agarwal V, Gupta L; COVAD study group. Joshi M, et al. Among authors: kuwana m. Int J Rheum Dis. 2024 May;27(5):e15161. doi: 10.1111/1756-185X.15161. Int J Rheum Dis. 2024. PMID: 38720408
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies.
Kadam E, Javaid M, Sen P, Saha S, Ziade N, Day J, Wincup C, Andreoli L, Parodis I, Tan AL, Shinjo SK, Dey D, Cavagna L, Chatterjee T, Knitza J, Wang G, Dalbeth N, Velikova T, Battista S, Cheng K, Boyd P, Kobert L, Gracia-Ramos AE, Mittal S, Makol A, Gutiérrez CET, Uribe CVC, Kuwana M, Burmester GR, Guillemin F, Nikiphorou E, Chinoy H, Aggarwal V, Gupta L; COVAD Study Group. Kadam E, et al. Among authors: kuwana m. Rheumatol Int. 2024 Apr 12. doi: 10.1007/s00296-024-05562-z. Online ahead of print. Rheumatol Int. 2024. PMID: 38609655
Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.
Oldroyd AGS, Callen JP, Chinoy H, Chung L, Fiorentino D, Gordon P, Machado PM, McHugh N, Selva-O'Callaghan A, Schmidt J, Tansley SL, Vleugels RA, Werth VP; International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group; Aggarwal R. Oldroyd AGS, et al. Nat Rev Rheumatol. 2024 May;20(5):315. doi: 10.1038/s41584-024-01111-x. Nat Rev Rheumatol. 2024. PMID: 38548933 No abstract available.
Correspondence on 'Current myositis clinical trials and tribulations' by Saygin et al.
Azevedo SF, Valenzuela A, Benitez CA, Isenberg DA, Naddaf E, Chinoy H, Vencovský J, Gupta L, McCann L, Kuwana M, Dimachkie MM, Shenoi S, Saketkoo LA, Machado PM. Azevedo SF, et al. Among authors: kuwana m. Ann Rheum Dis. 2024 Mar 28:ard-2024-225751. doi: 10.1136/ard-2024-225751. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38548314 No abstract available.
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey.
Yoshida A, Li Y, Maroufy V, Kuwana M, Sazliyana Shaharir S, Makol A, Sen P, Lilleker JB, Agarwal V, Kadam E, Akawatcharangura Goo P, Day J, Milchert M, Chen YM, Dey D, Velikova T, Saha S, Edgar Gracia-Ramos A, Parodis I, Nikiphorou E, Tan AL, Nune A, Cavagna L, Toro Gutiérrez CE, Caballero-Uribe CV, Saavedra MA, Shinjo SK, Ziade N, El Kibbi L, Knitza J, Distler O, Chinoy H, Agarwal V, Aggarwal R, Gupta L; COVAD Study Group. Yoshida A, et al. Among authors: kuwana m. Rheumatol Adv Pract. 2024 Mar 4;8(2):rkae028. doi: 10.1093/rap/rkae028. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 38524696 Free PMC article.
550 results